Moderna, Pfizer and COVID-19

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
Zacks Investment Research on MSN15h
Here's Why Moderna Stock Soared 16% on Wednesday
Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on ...
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...